Food allergy has become an important food quality and safety issue,posing a challenge to the food industry and affecting consumer health.On the one hand,from the perspective of food processing industry,the diversity o...Food allergy has become an important food quality and safety issue,posing a challenge to the food industry and affecting consumer health.On the one hand,from the perspective of food processing industry,the diversity of food raw material ingredients,exogenous additives,and processing forms make the presence of allergens in modern food processing more complex.In addition,due to the lack of allergen identification,effective detection and allergenicity evaluation systems,there are serious deficiencies in the current theories and techniques for food allergen screening and detection,tracking and prediction,intervention and control;On the other hand,from the perspective of public health,meeting consumers'right to know whether there are raw materials containing food allergens in processed foods,and improving the credibility of government and people's satisfaction have become urgent matters;In addition,as people come into contact with more and more new borne novel foods,the probability of food allergy is also increasing.The food safety and health problems induced by increasingly complex,widespread and severe food allergy are difficult to avoid.In view of this,in response to the increasingly serious food allergy issues,this paper introduced the detection methods of food allergens,summarized the reduction and control techniques of food allergens,and elaborated hypoallergenic foods,which aims to provide the basis for preventing and controlling food allergy and ensuring the physical health of food allergy patients.展开更多
Milk allergy is a common allergic reaction found in infants and young children,most of them appear tolerance after growing up.In this study,infant formula was digested by simulated in vitro digestion method.The potent...Milk allergy is a common allergic reaction found in infants and young children,most of them appear tolerance after growing up.In this study,infant formula was digested by simulated in vitro digestion method.The potential non-allergenic peptides were further screened from undigested products by exclusion of the known epitopes fromβ-lactoglobulin(BLG)andα-lactalbumin(ALA).These potential non-allergenic peptides were synthesized and their transferability were determined by Caco-2 cell monolayer model.Finally,the potential allergenicity were evaluated by KU812 cell degranulation model.The results showed that 7 peptides were screened as non-allergenic sequences,among which were 3 from ALA and 4 from BLG.The Caco-2 cell model showed that all the synthetic peptides were absorbed and transported well.However,only peptide BLG_(107-118)showed potential allegencity by KU812 model.In conclusion,6 peptides,including ALA_(29-51),ALA_(80-90),ALA_(94-103),BLG_(1-20),BLG_(24-50),and BLG_(123-139)were evaluated as hypoallergenic peptides,which could be used for candidates of peptides inducing immune tolerance for persons with milk allergy.展开更多
构建经基因工程改造的Ara h 2表达载体,表达并纯化该蛋白,鉴定其过敏原性。将花生主要过敏原Arah 2基因序列进行颠换,并将颠换后的序列进行合成,再将合成后的基因克隆到原核表达载体pET-32a(+)上,然后转入Origami宿主表达菌中;利用Isopr...构建经基因工程改造的Ara h 2表达载体,表达并纯化该蛋白,鉴定其过敏原性。将花生主要过敏原Arah 2基因序列进行颠换,并将颠换后的序列进行合成,再将合成后的基因克隆到原核表达载体pET-32a(+)上,然后转入Origami宿主表达菌中;利用Isopropylβ-D-1-Thiogalactopyranoside(IPTG)诱导表达;通过Ni2+亲和层析纯化目的蛋白;Western blotting和ELISA鉴定该重组蛋白的过敏原性。测序结果表明合成后的序列成功整合到原核表达载体pET-32a(+)上。重组的目的蛋白纯化后经SDS-PAGE鉴定,蛋白大小与理论值相符。Western blotting和ELISA结果均表明经基因工程改造的Ara h 2(F-Ara h 2)蛋白与重组的Ara h 2(R-Ara h 2)蛋白相比,结合花生过敏患者混合血清中IgE显著降低。成功构建经基因工程改造的Ara h 2表达载体,初步的体外实验表明该基因表达的重组蛋白具有低致敏原性。展开更多
Introduction: The Cussons Baby Sensicare Range is a newly developed set of products specially formulated for newborn, sensitive and eczema prone skin. As such, these products need to be tested to evaluate their skin i...Introduction: The Cussons Baby Sensicare Range is a newly developed set of products specially formulated for newborn, sensitive and eczema prone skin. As such, these products need to be tested to evaluate their skin irritation and sensitization potential before use. The products were evaluated with two separate tests. The first test was conducted in a single-center, within-subject comparison using assessor-blind, randomised human skin irritation patch test (48 hour/96 hour exposure) and conducted on healthy adults with sensitive, atopic skin. The second test was conducted in a single-center, controlled (sterile water), within subject using human repeat-insult patch tests (HRIPTs) and conducted on healthy female Indonesian and Asian adult female subjects, with sensitive skin. The sensitization potential of each product was determined from International Contact Dermatitis Research Group (ICDRG) scores at 30 minutes, 24 hours, 48 hours and 72 hours after patch removal. Skin irritation tests show that all products were significantly lower than the positive control sodium lauryl sulphate (SLS) (p < 0.05) but not significantly different to the negative control (sterile water) in terms of irritation scores at the respective time points. HRIPTs results show that Cussons Baby Sensicare Range was non-sensitizing. As such, it can be concluded that the Cussons Baby Sensicare Range tested is well tolerated on skin and has low skin irritation and sensitization potential. Thus, they can be considered hypoallergenic on sensitive skin and suitable for eczema prone skin.展开更多
目的构建经点突变的Ara h 2表达载体,表达并纯化该蛋白,鉴定其过敏原性。方法将Ara h 2基因进行点突变,并将其序列进行合成,再将合成后的基因连入原核表达载体pET-32a(+)上,然后转入BL21(DE3)宿主表达菌中;IPTG诱导表达;通过Ni2+亲和层...目的构建经点突变的Ara h 2表达载体,表达并纯化该蛋白,鉴定其过敏原性。方法将Ara h 2基因进行点突变,并将其序列进行合成,再将合成后的基因连入原核表达载体pET-32a(+)上,然后转入BL21(DE3)宿主表达菌中;IPTG诱导表达;通过Ni2+亲和层析(FPLC)纯化目的蛋白;Western-blotting和ELISA检测该重组蛋白的过敏原性。结果测序结果表明合成后的序列成功转入原核表达载体pET-32a(+)上。重组蛋白纯化后经SDS-PAGE鉴定,目的蛋白大小与理论值相符。Western-blotting和ELISA结果均表明经点突变的Ara h 2蛋白(M-Ara h 2)与重组的Ara h 2(R-Ara h 2)蛋白相比,结合花生过敏病人混合血清中IgE显著降低。结论成功构建了经点突变的Ara h 2表达载体,初步的体外实验表明该基因表达的重组蛋白具有低致敏原的潜能。展开更多
目的制备花生主要过敏原Ara h 2三聚体重组蛋白并检测其过敏原性。方法利用分子生物学的方法将3分子的Ara h 2依次串联起来,并将其整合到原核表达载体pET-32a(+),再转化到感受态Origami中;然后利用IPTG诱导其表达;通过Ni2+亲和层析纯化...目的制备花生主要过敏原Ara h 2三聚体重组蛋白并检测其过敏原性。方法利用分子生物学的方法将3分子的Ara h 2依次串联起来,并将其整合到原核表达载体pET-32a(+),再转化到感受态Origami中;然后利用IPTG诱导其表达;通过Ni2+亲和层析纯化三聚体重组蛋白;Western-blotting和ELISA检测目的蛋白的过敏原性。结果测序结果表明Trimer成功整合到pET-32a(+)上。三聚体重组蛋白纯化后经SDS-PAGE鉴定,蛋白大小与理论值相符。Western-blotting和ELISA结果表明Trimer与重组的Ara h 2(r-Ara h 2)蛋白相比,结合花生过敏病人混合血清中IgE的能力有所降低。结论成功制备花生主要过敏原Ara h 2三聚体重组蛋白,初步的体外实验表明该重组蛋白具有低致敏原的潜能。展开更多
基金The authors appreciated the financial support from National Natural Science Foundation of China(32102091)Shandong Provincial Natural Science Foundation(ZR2021QC086)+3 种基金China Postdoctoral Science Foundation(2021M693026)Postdoctoral Innovation Project of Shandong Province(862105033022)Qingdao Postdoctoral Applied Research Project(862105040045)Research Funding of Ocean University of China(862001013187).
文摘Food allergy has become an important food quality and safety issue,posing a challenge to the food industry and affecting consumer health.On the one hand,from the perspective of food processing industry,the diversity of food raw material ingredients,exogenous additives,and processing forms make the presence of allergens in modern food processing more complex.In addition,due to the lack of allergen identification,effective detection and allergenicity evaluation systems,there are serious deficiencies in the current theories and techniques for food allergen screening and detection,tracking and prediction,intervention and control;On the other hand,from the perspective of public health,meeting consumers'right to know whether there are raw materials containing food allergens in processed foods,and improving the credibility of government and people's satisfaction have become urgent matters;In addition,as people come into contact with more and more new borne novel foods,the probability of food allergy is also increasing.The food safety and health problems induced by increasingly complex,widespread and severe food allergy are difficult to avoid.In view of this,in response to the increasingly serious food allergy issues,this paper introduced the detection methods of food allergens,summarized the reduction and control techniques of food allergens,and elaborated hypoallergenic foods,which aims to provide the basis for preventing and controlling food allergy and ensuring the physical health of food allergy patients.
基金supported by National Key R&D Program of China(2018YFC1604205)the National Natural Science Foundation of China(31760431)State Key Laboratory of Food Science and Technology,Nanchang University(SKLF-ZZA-201912)。
文摘Milk allergy is a common allergic reaction found in infants and young children,most of them appear tolerance after growing up.In this study,infant formula was digested by simulated in vitro digestion method.The potential non-allergenic peptides were further screened from undigested products by exclusion of the known epitopes fromβ-lactoglobulin(BLG)andα-lactalbumin(ALA).These potential non-allergenic peptides were synthesized and their transferability were determined by Caco-2 cell monolayer model.Finally,the potential allergenicity were evaluated by KU812 cell degranulation model.The results showed that 7 peptides were screened as non-allergenic sequences,among which were 3 from ALA and 4 from BLG.The Caco-2 cell model showed that all the synthetic peptides were absorbed and transported well.However,only peptide BLG_(107-118)showed potential allegencity by KU812 model.In conclusion,6 peptides,including ALA_(29-51),ALA_(80-90),ALA_(94-103),BLG_(1-20),BLG_(24-50),and BLG_(123-139)were evaluated as hypoallergenic peptides,which could be used for candidates of peptides inducing immune tolerance for persons with milk allergy.
文摘构建经基因工程改造的Ara h 2表达载体,表达并纯化该蛋白,鉴定其过敏原性。将花生主要过敏原Arah 2基因序列进行颠换,并将颠换后的序列进行合成,再将合成后的基因克隆到原核表达载体pET-32a(+)上,然后转入Origami宿主表达菌中;利用Isopropylβ-D-1-Thiogalactopyranoside(IPTG)诱导表达;通过Ni2+亲和层析纯化目的蛋白;Western blotting和ELISA鉴定该重组蛋白的过敏原性。测序结果表明合成后的序列成功整合到原核表达载体pET-32a(+)上。重组的目的蛋白纯化后经SDS-PAGE鉴定,蛋白大小与理论值相符。Western blotting和ELISA结果均表明经基因工程改造的Ara h 2(F-Ara h 2)蛋白与重组的Ara h 2(R-Ara h 2)蛋白相比,结合花生过敏患者混合血清中IgE显著降低。成功构建经基因工程改造的Ara h 2表达载体,初步的体外实验表明该基因表达的重组蛋白具有低致敏原性。
文摘Introduction: The Cussons Baby Sensicare Range is a newly developed set of products specially formulated for newborn, sensitive and eczema prone skin. As such, these products need to be tested to evaluate their skin irritation and sensitization potential before use. The products were evaluated with two separate tests. The first test was conducted in a single-center, within-subject comparison using assessor-blind, randomised human skin irritation patch test (48 hour/96 hour exposure) and conducted on healthy adults with sensitive, atopic skin. The second test was conducted in a single-center, controlled (sterile water), within subject using human repeat-insult patch tests (HRIPTs) and conducted on healthy female Indonesian and Asian adult female subjects, with sensitive skin. The sensitization potential of each product was determined from International Contact Dermatitis Research Group (ICDRG) scores at 30 minutes, 24 hours, 48 hours and 72 hours after patch removal. Skin irritation tests show that all products were significantly lower than the positive control sodium lauryl sulphate (SLS) (p < 0.05) but not significantly different to the negative control (sterile water) in terms of irritation scores at the respective time points. HRIPTs results show that Cussons Baby Sensicare Range was non-sensitizing. As such, it can be concluded that the Cussons Baby Sensicare Range tested is well tolerated on skin and has low skin irritation and sensitization potential. Thus, they can be considered hypoallergenic on sensitive skin and suitable for eczema prone skin.
文摘目的构建经点突变的Ara h 2表达载体,表达并纯化该蛋白,鉴定其过敏原性。方法将Ara h 2基因进行点突变,并将其序列进行合成,再将合成后的基因连入原核表达载体pET-32a(+)上,然后转入BL21(DE3)宿主表达菌中;IPTG诱导表达;通过Ni2+亲和层析(FPLC)纯化目的蛋白;Western-blotting和ELISA检测该重组蛋白的过敏原性。结果测序结果表明合成后的序列成功转入原核表达载体pET-32a(+)上。重组蛋白纯化后经SDS-PAGE鉴定,目的蛋白大小与理论值相符。Western-blotting和ELISA结果均表明经点突变的Ara h 2蛋白(M-Ara h 2)与重组的Ara h 2(R-Ara h 2)蛋白相比,结合花生过敏病人混合血清中IgE显著降低。结论成功构建了经点突变的Ara h 2表达载体,初步的体外实验表明该基因表达的重组蛋白具有低致敏原的潜能。
文摘目的制备花生主要过敏原Ara h 2三聚体重组蛋白并检测其过敏原性。方法利用分子生物学的方法将3分子的Ara h 2依次串联起来,并将其整合到原核表达载体pET-32a(+),再转化到感受态Origami中;然后利用IPTG诱导其表达;通过Ni2+亲和层析纯化三聚体重组蛋白;Western-blotting和ELISA检测目的蛋白的过敏原性。结果测序结果表明Trimer成功整合到pET-32a(+)上。三聚体重组蛋白纯化后经SDS-PAGE鉴定,蛋白大小与理论值相符。Western-blotting和ELISA结果表明Trimer与重组的Ara h 2(r-Ara h 2)蛋白相比,结合花生过敏病人混合血清中IgE的能力有所降低。结论成功制备花生主要过敏原Ara h 2三聚体重组蛋白,初步的体外实验表明该重组蛋白具有低致敏原的潜能。
